Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Investors Show Strong Interest in Progressive NYSEPGR Through Options Trading Surge

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
MA stock news
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Investors with significant capital are showing a strong interest in Progressive (NYSE:PGR) as seen through a recent surge in options trading activity. Today, a total of 28 options trades for Progressive were identified by Benzinga’s options scanner, marking an unusual occurrence in the market. The sentiment among these high-profile traders is evenly split between bullish and bearish positions, with a notable $30,800 put trade and $2,733,651 in call trades.
Analysis of the volume and open interest in these contracts indicates that major players have been focusing on a price range of $145.0 to $210.0 for Progressive in the past quarter. Fluctuations in volume and open interest for calls and puts within this range have been closely monitored over the last 30 days.
The most significant options trades observed include bearish and bullish call trades expiring on 05/17/24 at a strike price of $200.00, with varying total trade prices and volumes. Progressive is a leading insurer in the U.S., specializing in private and commercial auto insurance policies. The current trading volume stands at 1,355,850, with the stock price at $200.0, reflecting a 0.8% increase. However, RSI indicators suggest the stock may be overbought, with an upcoming earnings announcement in 31 days.
Expert analysis predicts an average price target of $244.0 for Progressive, with analysts at B of A Securities maintaining a Buy rating and a price target of $261, while Morgan Stanley has upgraded its recommendation to Overweight with a target of $227. Options trading is considered riskier than stock trading but offers higher profit potential. Serious options traders manage this risk through continuous education, strategic trade management, and vigilant market monitoring.

Progressive Corporation (PGR) Stock Update: March 11, 2024 – Strong Price Momentum and After-Hours Rebound

Progressive Corporation (PGR) had a mixed day in the stock market on March 11, 2024. The insurance company’s stock closed at $196.74, which was a decrease of $1.67 or 0.84% from the previous market close. Despite this slight drop in price, PGR is still trading near the top of its 52-week range and above its 200-day simple moving average, indicating strong price momentum for the stock.

After the market closed, PGR saw a small rebound in after-hours trading, with the stock rising $1.26. This uptick in price suggests that investors may be feeling more bullish about the company’s prospects in the near future.

Progressive Corporation (PGR) Reports Impressive Financial Growth in Latest Data: Revenue up 25.2%

Progressive Corporation (PGR) has been showing impressive growth in its financial performance according to the latest data released on March 11, 2024. The total revenue for the company stood at $62.08 billion for the past year, marking a significant increase of 25.2% compared to the previous year. In the last quarter alone, the total revenue was reported at $16.88 billion, reflecting a growth of 8.55% since the previous quarter.

The net income for Progressive Corporation was reported at $3.90 billion for the past year, showing a substantial increase of 440.87% compared to the previous year. However, the net income remained flat at $1.99 billion since the last quarter. Despite this, the company’s earnings per share (EPS) showed a remarkable growth of 456.03% since the previous year, with the EPS standing at $6.58. However, the EPS held flat at $3.37 since the last quarter.

Investors and analysts have been closely monitoring Progressive Corporation’s financial performance, and the latest data indicates a strong growth trajectory for the company. The increase in total revenue, net income, and EPS demonstrates the company’s ability to drive growth and profitability in a competitive market environment.

Progressive Corporation is a well-known insurance company that offers a wide range of insurance products and services to its customers. The company’s strong financial performance is a testament to its efficient business operations and strategic initiatives that have helped drive growth and profitability.

Overall, the latest data on Progressive Corporation’s stock performance on March 11, 2024, highlights the company’s strong financial performance and growth prospects. Investors and analysts are optimistic about the company’s future outlook, given its impressive revenue growth and profitability metrics.

Tags: PGR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Food Retailers Market Capitalization

Nikes Stock Soars as Analysts Remain Bullish

Automotive Stock Market Today

Advance Auto Parts Welcomes New Board Members in Settlement with Activist Investors

Assertio Holdings NASDAQ ASRT Reports Strong Q4 2023 Earnings Despite Sales Decline

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com